Patent intelligence · US
US 12016929
Lipid formulations for delivery of therapeutic agents
Lipid formulations for delivery of therapeutic agents
Patent details — US 12016929
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 25, 2024
- Expiration
- Jun 20, 2044
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Claims
- 22
- CPC classes
- A61K, A61K31/713, A61K47/44, A61K47/543
Quick answer
US 12016929 (Lipid formulations for delivery of therapeutic agents) is held by ARBUTUS BIOPHARMA CORPORATION. Status: granted. Granted Jun 25, 2024. Expires Jun 20, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- ARBUTUS BIOPHARMA CORPORATION
- Grant date
- Expiration
- Claims
- 22
- CPC classes
- A61K, A61K31/713, A61K47/44, A61K47/543, A61K9/0019, A61K9/1272
More from ARBUTUS BIOPHARMA CORPORATION
Related pharmaceutical patents in our USPTO index.
-
US 12357705
Negatively charged peg-lipid conjugates
granted -
US 12350383
Cationic lipids containing silicon
granted -
US 12251470
Lipid nanoparticle formulations
granted -
US 12129467
Non-liposomal systems for nucleic acid delivery
granted -
US 12083118
Substituted 1,1′-biphenyl compounds, analogues thereof, and methods using same
granted -
US 12043833
Targeted compositions
granted -
US 12042541
Lipids and compositions for the delivery of therapeutics
granted -
US 12023383
Lipid compositions
granted
Frequently asked questions
What is US patent 12016929?
US 12016929 (Lipid formulations for delivery of therapeutic agents) is held by ARBUTUS BIOPHARMA CORPORATION. Status: granted. Granted Jun 25, 2024. Expires Jun 20, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12016929?
ARBUTUS BIOPHARMA CORPORATION is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 56 pharmaceutical patents for this assignee.
When does US 12016929 expire?
Our index shows an expiration date of Jun 20, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.